Patent Applications with Amino Acid Claims

The applications listed below recite at least one amino acid sequence in the claims that has a high degree of similarity to an influenza peptide sequence. For each application, we show the sequences that are similar to or identical to an influenza sequence.  Although most all of the applications recite multiple sequences in the published claims, there is generally only one or a few claims in prosecution.  The last column shows the non-U.S. jurisdictions where related applications have been filed. No information is provided here regarding the status of these applications.

This set of applications was identified using blastp. The criteria for inclusion in this table is that the patent claim sequences were at least 80% identical to an influenza peptide sequence.

Of the 57 applications in the table below, 40 are assigned to corporations and 17 are assigned to non-profit organizations.

Application No. Assignee Title Sequence IDs in Claims Similar to Influenza Other Jurisdictions with Family Members
20050208066 Academia Sinica Recombinant baculovirus and virus-like particle 10
20070224594 Arbor Vita Corporation Detection of influenza virus 4 Australia, Canada, Europe
20030099670 Artemis Pharmaceuticals GMBH Influenza viruses with enhanced transcriptional and replicational capacities 25,27,29,31,33,35,37,39,41,43,45,47 Australia, Europe, Japan
20070026009 Inventors:Samuel Bogoch et al. Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds 15 Australia, Brazil, Canada, China, Europe, Israel, Japan, Korea, New Zealand
20050059107 Comissariat A L’Energie Atomique Method of selecting hla-dp4 ligands and the applications thereof 5 Australia, Canada, Europe, France
20020081680 Corixa Corp. Compositions and methods for the therapy and diagnosis of prostate cancer 973 Austria, Australia, Brazil, Canada, China, Czech Republic, Germany, Denmark, Europe, Spain, United Kingdom, Hungary, Israel, Japan, Korea, Mexico, Norway, New Zealand, Poland, Russian Federation, Turkey, South Africa
20020192763 Corixa Corp. Compositions and methods for the therapy and diagnosis of prostate cancer 973 Austria, Australia, Brazil, Canada, China, Czech Republic, Germany, Denmark, Europe, Spain, United Kingdom, Hungary, Israel, Japan, Korea, Mexico, Norway, New Zealand, Poland, Russian Federation, Turkey, Taiwan, South Africa
20070253981 Cornell Research Foundation Canine Influenza Virus 2 World
20040180058 Curelab, Inc. Vaccine compositions and methods 3,4 Australia, Canada, Europe, Japan
20070048287 Cytos Biotechnology AG Molecular antigen array 213 Australia, Brazil, Canada, China, Europe, Israel, Japan, Korea
20070286871 Diversa Corporation Vaccines 6 Canada, United Kingdom, Norway
20040268442 Dow AgroSciences LLC Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production 4 Australia, Brazil, Canada, China, Europe, Japan, Korea
20060222664 Dow AgroSciences LLC Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production 4 Australia, Brazil, Canada, China, Europe, Japan, Korea
20070107086 Dow AgroSciences LLC Preparation of vaccine master cell lines using recombinant plant suspension cultures 4 Argentina, World
20070275014 Fraunhofer U.S.A. Inc. Influenza antigens, vaccine compositions, and related methods 1,2,3,4,7,8,11,12,13,16,18,20,24 Australia, Canada, China, Europe
20060188469 General Electric Company Vaccine delivery compositions and methods of use 9 Austria, Australia, Canada, China, Germany, Europe, Spain, Japan, Korea
20040202673 Genesis Biotech, Inc. Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes 1 China
20050106563 Genesis Biotech, Inc. Epitope profiles of SARS coronavirus 5,6
20070042001 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine 1,2,3,4,5,6,7 World
20070042002 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine 1,2,3,4,5,6,7,8,9,10,11 World
20080008725 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine 1,2,3,4,5,6,7,8,9,10 World
20070092536 Heska Corporation Cold-adapted equine influenza viruses 6,9,14,22,25,28,33,37,40,43,46,49,54,62,64,67,69,72,77,85,88,96,99,101,103,105,107,109,111,112,114,116,118,120,122,124,126,128,130 Austria, Australia, Canada, Germany, Denmark, Europe, Spain, Japan
20070172494 Heska Corporation Cold-adapted equine influenza viruses 17,24 Australia, Brazil, Canada, China, Germany, Europe, Spain, Japan, Korea
20070196388 Heska Corporation Cold-adapted equine influenza viruses 2,5,8,14,17,20,24 Austria, Australia, Canada, Germany, Denmark, Europe, Spain, Japan
20040137015 The University of Pittsburgh Cold-adapted equine influenza viruses 2,5,8,11,14,17,20,24,45,48,51,55,58,63,66,69,77,81,86,89,92,95,104,107 Austria, Australia, Canada, Germany, Denmark, Europe, Spain, Japan
20030099634 IDM Pharma, Inc. Compositions and methods for eliciting CTL immunity 99 Austria, Australia, Bulgaria, Brazil, Canada, China, Czech Republic, Germany, Denmark, Europe, Spain, Finland, Finland, Greece, Hungary, Hungary, Israel, Japan, Mexico, Norway, New Zealand, OAPI, Portugal, Russian Federation, Singapore, Slovakia, South Africa
20060293262 Immune Disease Institute, Inc. Inhibition of gene expression using RNA interfering agents 28 Australia, Europe, Japan
20030108561 Innogenetics N.V. Core-glycosylated HCV envelope proteins 82 ARIPO, Australia, Bulgaria, Brazil, Canada, China, Czech Republic, Europe, Croatia, Hungary, Israel, Japan, Mexico, New Zealand, Poland, Russian Federation, Slovakia, Yugoslavia, South Africa
20030152940 Innogenetics N.V. Constructs and methods for expression of recombinant HCV envelope proteins 82 ARIPO, Australia, Bulgaria, Brazil, Canada, China, Czech Republic, Europe, Croatia, Hungary, Israel, Japan, Mexico, New Zealand, Poland, Russian Federation, Slovakia, Yugoslavia, South Africa
20080008683 Institut Gustave Rjoussy, Centre National de la Recherche Scientifique, and Universite Paris Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins 36,72 Australia, Brazil, Canada, China, Europe, Japan
20070098742 Iowa State University Research Foundation Canine influenza virus and related compositions and methods of use 2,4,6,8,10,12,14,16 Argentina, World
20030219442 Kirin Beer Human monoclonal antibodies to influenza M2 protein and methods of making and using same 1,2,3,4,5,6,7,8 Australia, Canada, China, Europe, Japan
20050170334 Kirin Pharma Kabushiki Kaisha Human monoclonal antibodies to influenza M2 protein and methods of making and using same 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,24 Australia, Canada, China, Europe, Japan
20050042229 MedImmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants 35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68 Canada, Europe
20060008473 MedImmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants 11,12,13,14,15,16,17,18,19,20 Australia, Canada, Europe, Japan
20070160622 MediVas Method for assembling a polymer-biologic delivery composition 11,12,13,14,16 Austria, Australia, Canada, China, Germany, Europe, Spain, Japan, Korea
20040223976 Merck & Co. Inc Influenza virus vaccine 1,2,10,39,59,60,61,62,126,127,128,129,130,131,132,133,1,135,136,137,138,139,143,144,145,146,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168 Australia, Brazil, Canada, China, Europe, Japan, Korea, Mexico, Norway, Russian Federation, South Africa
20060018903 Merck Patent GMBH TNF alpha-binding polypeptide compositions and methods 21 Brazil, Canada, China, Europe, Hungary, Japan, Korea, Mexico, Poland, Russian Federation, South Africa
20080003203 National Tsing Hua University Pseudotyped baculovirus to stimulate immunogenicity against avian influenza 1
20070184526 Novavax, Inc. Functional influenza virus like particles (VLPs) 43 Australia, Brazil, Canada, China, Europe, Japan, Korea, Mexico, Russian Federation, Singapore
20030175285 PF Medicament Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid 189,527,529 Australia, Brazil, Canada, China, Europe, France, Japan, Mexico, South Africa
20080032921 Pharmexa Inc. Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions 5,6,7,8,186
20050234222 Photobiotics Ltd. Conjugate 6 Canada, Europe, United Kingdom, Japan
20040006022 President and Fellows of Harvard College Synthetic peptides and methods of use for autoimmune disease therapies 1 Australia, Canada, Europe, Hungary, Israel, Japan, Norway, New Zealand, South Africa
20020165176 Powerject Vaccines Nucleic acid immunization 1,2,3 Australia, Europe
20070066534 Queensland Institute Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes 1,5,7,18,107,108,111,112 Australia, Brazil, Canada, China, Europe, Japan, Korea
20070160631 Queensland Institute Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes 1,3,4 Australia, Brazil, Canada, China, Europe, Japan, Korea
20060222657 The Regents of the University of California Polypeptide transduction and fusogenic peptides 2,3 Australia, Canada, Europe
20050191318 Research Development Foundation DNA immunocontraceptive vaccines and uses thereof 15
20030148928 Ribozyme Pharmaceuticals, Inc. Enzymatic nucleic acid peptide conjugates 19 Australia
20030157118 Smithkline Beecham Biologicals Tumour-specific animal proteins 10 Australia, Brazil, Canada, China, Czech Republic, Europe, United Kingdom, Hungary, Israel, Japan, Mexico, Norway, New Zealand, Poland, South Africa
20060280754 Tulane Educational Fund Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins 4 Australia, Brazil, Canada, Europe, Japan
20050074813 U.S. Army Model for testing immunogenicity of peptides 1 ARIPO, Australia, Brazil, Canada, China, Europe, Japan, New Zealand
20060024670 Vical Inc. Influenza virus vaccine composition and methods of use 76,78 Australia, Canada, Europe, Japan
20060153871 Wisconsin Alumni Research Foundation H3 equine influenza A virus 1,2,3,4,5,6,7,8,17,18
20070059806 Yeda Research and Development Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection 1,13,14,15 Australia, Canada, Europe, Japan, Korea, Mexico, New Zealand, Poland, Russian Federation, South Africa
20070122424 Yeda Research and Development Peptide-Based Vaccine for Influenza 1,2,3,4,5 Australia, Brazil, Canada, Europe, Israel, Japan, New Zealand